Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HADSTEN FYSIOTERAPI & TRÆNING, AUTORISEREDE FYSIOTERAPEUTER ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   7.9% 9.5% 13.8% 10.4% 6.6% 6.6% 12.0% 11.8%   Credit score (0-100)   32 27 16 22 35 35 20 20   Credit rating   BB BB BB BB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,155 4,787 3,944 4,364 5,327 6,313 0.0 0.0   EBITDA   -295 87.8 353 393 723 929 0.0 0.0   EBIT   -440 -75.5 172 299 566 773 0.0 0.0   Pre-tax profit (PTP)   -445.2 -113.9 150.3 272.2 552.3 761.4 0.0 0.0   Net earnings   -349.4 -89.7 115.6 212.0 430.0 593.0 0.0 0.0   Pre-tax profit without non-rec. items   -445 -114 150 272 552 761 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   318 259 120 480 365 512 0.0 0.0   Shareholders equity total   215 125 241 453 683 1,026 601 601   Interest-bearing liabilities   573 506 460 240 150 2.8 0.0 0.0   Balance sheet total (assets)   1,431 1,289 1,668 1,572 1,465 1,818 601 601   Net Debt   568 499 455 237 -212 -309 -530 -530     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,155 4,787 3,944 4,364 5,327 6,313 0.0 0.0   Gross profit growth   -13.2% 15.2% -17.6% 10.6% 22.1% 18.5% -100.0% 0.0%   Employees   10 10 8 8 9 11 0 0   Employee growth %   0.0% 0.0% -20.0% 0.0% 12.5% 22.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,431 1,289 1,668 1,572 1,465 1,818 601 601   Balance sheet change%   11.1% -10.0% 29.4% -5.8% -6.8% 24.1% -66.9% 0.0%   Added value   -294.6 87.8 353.2 392.9 659.5 929.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -43 -265 -363 223 -315 -53 -512 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -2.0 -3.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -10.6% -1.6% 4.4% 6.9% 10.6% 12.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -31.7% -5.4% 11.7% 18.5% 37.4% 47.1% 0.0% 0.0%   ROI %   -56.3% -9.6% 23.9% 43.1% 73.4% 80.8% 0.0% 0.0%   ROE %   -205.3% -52.7% 63.1% 61.1% 75.7% 69.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   15.0% 9.7% 14.4% 28.8% 46.6% 56.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -192.8% 568.0% 128.9% 60.2% -29.3% -33.3% 0.0% 0.0%   Gearing %   266.4% 403.8% 190.8% 53.1% 21.9% 0.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.5% 7.4% 4.6% 8.0% 8.0% 16.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.6 0.6 0.9 0.7 1.3 1.4 0.0 0.0   Current Ratio   0.6 0.6 0.9 0.7 1.3 1.4 0.0 0.0   Cash and cash equivalent   4.8 7.6 4.5 3.8 361.5 312.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -493.1 -379.3 -197.2 -334.2 212.2 313.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -29 9 44 49 73 84 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -29 9 44 49 80 84 0 0   EBIT / employee   -44 -8 21 37 63 70 0 0   Net earnings / employee   -35 -9 14 26 48 54 0 0